Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients

J. Davies; A. Gavin; M. Band; A. Morris; A. Struthers

doi:10.1111/j.1365-2125.2005.02363.x

Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients

J. Davies
, A. Gavin
, M. Band
, A. Morris
, A. Struthers

Research output: Contribution to journal › Article › peer-review

36 Citations (Scopus)

Abstract

To assess whether spironolactone has beneficial effects on blood pressure (BP), N-terminal propeptide of type III procollagen (PIIINP) and pulse wave velocity (PWV) in hypertensive, type II diabetics.

Original language	English
Pages (from-to)	520-3
Number of pages	4
Journal	British Journal of Clinical Pharmacology
Volume	59
Issue number	5
DOIs	https://doi.org/10.1111/j.1365-2125.2005.02363.x
Publication status	Published - May 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1365-2125.2005.02363.x

Cite this

@article{07012a7001dc4b0d889cbfcaf4aaed6d,

title = "Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients",

abstract = "To assess whether spironolactone has beneficial effects on blood pressure (BP), N-terminal propeptide of type III procollagen (PIIINP) and pulse wave velocity (PWV) in hypertensive, type II diabetics.",

author = "J. Davies and A. Gavin and M. Band and A. Morris and A. Struthers",

year = "2005",

month = may,

doi = "10.1111/j.1365-2125.2005.02363.x",

language = "English",

volume = "59",

pages = "520--3",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients

AU - Davies, J.

AU - Gavin, A.

AU - Band, M.

AU - Morris, A.

AU - Struthers, A.

PY - 2005/5

Y1 - 2005/5

N2 - To assess whether spironolactone has beneficial effects on blood pressure (BP), N-terminal propeptide of type III procollagen (PIIINP) and pulse wave velocity (PWV) in hypertensive, type II diabetics.

AB - To assess whether spironolactone has beneficial effects on blood pressure (BP), N-terminal propeptide of type III procollagen (PIIINP) and pulse wave velocity (PWV) in hypertensive, type II diabetics.

U2 - 10.1111/j.1365-2125.2005.02363.x

DO - 10.1111/j.1365-2125.2005.02363.x

M3 - Article

C2 - 15842549

SN - 0306-5251

VL - 59

SP - 520

EP - 523

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 5

ER -

Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this